Grant: Project Grant
Research Institute of the McGill University Health Centre
$1,021,275.00
Repairing the brain of sick newborns: From bench to bedside
EF 2018-19
Résumé
At birth, some babies experienced a condition called asphyxia, which means that their brain and other organs did not receive enough blood and/or oxygen. This life-threatening condition accounts for 23% of all babies' deaths around the world, and often leads to cerebral palsy and trouble with learning and functioning in everyday life. At this time, no treatment is available to repair the brain damage in these babies. Sildenafil (Viagra®) already is given safely to babies suffering from increased blood pressure in their lungs for other reasons than asphyxia at birth. Our recent studies in an animal model of asphyxia at birth suggested that sildenafil may improve the damage to the brain. Also, our recent pilot study with human babies showed that it is feasible to give sildenafil to babies who suffer from asphyxia at birth.
We hypothesize that (1) sildenafil can repair the damage to a baby's brain by stimulating the growth of new nerve cells and decreasing brain swelling; and that (2) sildenafil can be safely increased up to 6 mg/kg/day in these babies and may improve how their brain and heart/lungs work. We will use a rat model of asphyxia at birth to study the mechanisms involved in repairing the brain after it is damaged. We also will determine the optimal dose of sildenafil that can be given to human babies who suffered from asphyxia at birth to improve their brain, heart, and lungs.
This project will enable us to understand the repair mechanisms involved in the damaged baby's brain after asphyxia at birth and to determine whether sildenafil is a promising treatment for repairing this damage. This project may provide new solutions for these babies to reduce the consequences of asphyxia at birth and improve their future life. Thus, it may help many families around the world who are dealing with this devastating condition.
Programme
Project Grant
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
387790
Name
Wintermark Pia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Clinical Investigation - A: Reproduction, Maternal, Child and Youth Health
Projecttitle
Repairing the brain of sick newborns: From bench to bedside
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,021,275
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Birth Asphyxia; Brain; Echocardiography; Magnetic Resonance Imaging; Near-Infrared Spectroscopy; Neuroinflammation; Neurorestoration; Newborn; Pharmacology
Abstract
At birth, some babies experienced a condition called asphyxia, which means that their brain and other organs did not receive enough blood and/or oxygen. This life-threatening condition accounts for 23% of all babies' deaths around the world, and often leads to cerebral palsy and trouble with learning and functioning in everyday life. At this time, no treatment is available to repair the brain damage in these babies. Sildenafil (Viagra®) already is given safely to babies suffering from increased blood pressure in their lungs for other reasons than asphyxia at birth. Our recent studies in an animal model of asphyxia at birth suggested that sildenafil may improve the damage to the brain. Also, our recent pilot study with human babies showed that it is feasible to give sildenafil to babies who suffer from asphyxia at birth.
We hypothesize that (1) sildenafil can repair the damage to a baby's brain by stimulating the growth of new nerve cells and decreasing brain swelling; and that (2) sildenafil can be safely increased up to 6 mg/kg/day in these babies and may improve how their brain and heart/lungs work. We will use a rat model of asphyxia at birth to study the mechanisms involved in repairing the brain after it is damaged. We also will determine the optimal dose of sildenafil that can be given to human babies who suffered from asphyxia at birth to improve their brain, heart, and lungs.
This project will enable us to understand the repair mechanisms involved in the damaged baby's brain after asphyxia at birth and to determine whether sildenafil is a promising treatment for repairing this damage. This project may provide new solutions for these babies to reduce the consequences of asphyxia at birth and improve their future life. Thus, it may help many families around the world who are dealing with this devastating condition.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Wintermark, Pia
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,021,275~ $0~